STARODUBOV, V.I.,
MARCZAK, L.B.,
VARAVIKOVA, E.,
BIKBOV, B.,
ERMAKOV, S.P.,
GALL, J.,
GLENN, S.D.,
GRISWOLD, M.,
IDRISOV, B.,
KRAVCHENKO, M.,
LIOZNOV, D.,
LOYOLA, E.,
RAKOVAC, I.,
VLADIMIROV, S.K.,
VLASSOV, V.,
MURRAY, C.J.L.,
NAGHAVI, M (2018) to health care. Ongoing mortality and disability from causes and risks amenable to health-care
interventionsPang, H.Y.,
Chen, X.L.,
Song, X.H.,
Galiullin, D.,
Zhao, L.Y.,
Liu, K,
Zhang, W.H.,
Yang, K,
Chen, X.Z.,
Hu, J.K. (2021) .0001; I2 = 22%). This
intervention was also associated with shorter postoperative stays (MD = − 1.27; 95
Zelinska, N.,
Iotova, V.,
Skorodok, J.,
Malievsky, O.,
Peterkova, V.,
Samsonova, L.,
Rosenfeld, Ron G.,
Zadik, Zvi,
Jaron-Mendelson, Michal,
Koren, Ronit,
Amitzi, Leanne,
Raduk, Dmitri,
Hershkovitz, Oren,
Hart, Gili (2017) of treatment with either
MOD-4023 (N = 42) or r-hGH (N = 11).
Interventions: C-terminal peptide–modified h
Chatelain, Pierre,
Malievskiy, Oleg,
Radziuk, Klaudziya,
Senatorova, Ganna,
Abdou, Magdy O.,
Vlachopapadopoulou, Elpis,
Skorodok, Yulia,
Peterkova, Valentina,
Leff, Jonathan A.,
Beckert, Michael (2017) .
Patients: Prepubertal male and female treatment-naive children with GHD (n = 53).
Interventions: Subjects
SEREDA, Y.,
KIRIAZOVA, T.,
MAKARENKO, O.,
CARROLL, J.J.,
RYBAK, N.,
GILLANI, F.S.,
FLANIGAN, T.,
CHYBISOV, A.,
BENDIKS, S.,
DUTTA, A.,
SAMET, J.H.,
LUNZE, K.,
IDRISOV, B. (2020) for this key population. Stigma
interventions for PWID, possibly delivered involving NGOs, may be an approach
ATAS, A.E.,
SARAC, A.,
DIRICAN, A.,
TOPBASI, N.,
UZAR, T.,
RASTGAR, L.,
PANKINA, E.,
OZKAYA, S. (2019) on our experience, early thrombolytic therapy is a life-saving
intervention in patients with diagnosed